An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome
Clinical trial NCT07410455 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07410455
- Sponsor
- Can-Fite BioPharma
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-08-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.